(Q53902292)
Statements
Olanzapine augmentation of fluvoxamine-refractory obsessive-compulsive disorder (OCD): a 12-week open trial. (English)
F Bogetto
S Bellino
P Vaschetto
S Ziero
1 October 2000
96
2
91-98
scientific article
No description defined